침 흘림에 대한 약물 치료 및 중재 요법
Pharmacologic and Interventional Approach for Drooling
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Drooling is defined as the unintentional loss of saliva from the mouth, which is described as anterior drooling, while posterior drooling is described as saliva spilling through the faucial isthmus creating a risk of aspiration. Drooling is a distressing symptom for the patients with neurological conditions such as cerebral palsy, Parkinson's disease, amyotrophic lateral sclerosis and stroke, because it causes physical and psychosocial problems that can have a negative impact on quality of life. A range of interventions such as behavioral approach, pharmacologic approach, botulinum toxin injection into salivary gland, radiotherapy or surgery, exist that aim to reduce drooling. But there is a lack of consensus on management approach, treatment dose or administration technique. Drooling will be best managed by a multidisciplinary team, starting with a conservative approach and then leading to more invasive procedures as appropriate. (JKDS 2013;3:37-42)
Abstract
Drooling is defined as the unintentional loss of saliva from the mouth, which is described as anterior drooling, while posterior drooling is described as saliva spilling through the faucial isthmus creating a risk of aspiration. Drooling is a distressing symptom for the patients with neurological conditions such as cerebral palsy, Parkinson's disease, amyotrophic lateral sclerosis and stroke, because it causes physical and psychosocial problems that can have a negative impact on quality of life. A range of interventions such as behavioral approach, pharmacologic approach, botulinum toxin injection into salivary gland, radiotherapy or surgery, exist that aim to reduce drooling. But there is a lack of consensus on management approach, treatment dose or administration technique. Drooling will be best managed by a multidisciplinary team, starting with a conservative approach and then leading to more invasive procedures as appropriate. (JKDS 2013;3:37-42)
참고문헌 (25)
- Blasco PA, "Surgical management of drooling", Dev Med Child Neurol, 34, pp.368~369 (1992)
- Jongerius PH, "The treatment of posterior drooling by botulinum toxin in a child with cerebral palsy", J Pediatr Gastroenterol Nutr, 41, pp.351~353 (2005)
- Reddihough D, "Botulinum toxin assessment, intervention and aftercare for paediatric and adult drooling: International consensus statement", Eur J Neurol, (Suppl 2), pp.109~121 (2010)
- Harris SR, "Drooling and its management in cerebral palsy", Dev Med Child Neurol, 29, pp.807~811 (1987)
- Blasco PA, "Drooling in the developmentally disabled: management practices and recommendations. Consortium on Drooling", Dev Med Child Neurol, 34, pp.849~862 (1992)
- Harriman M, "Use of radiotherapy for control of sialorrhea in patients with amyotrophic lateral sclerosis", J Otolaryngol, 30, pp.242~245 (2001)
- Tahmassebi JF, "Prevalence of drooling in children with cerebral palsy attending special schools", Dev Med Child Neurol, 45, pp.613~617 (2003)
- Kalf JG, "Botulinum toxin A for drooling in Parkinson's disease: a pilot study to compare submandibular to parotid gland injections", Parkinsonism Relat Disord, 13, pp.532~534 (2007)
- Dand P, "The management of drooling in motor neuron disease", Int J Palliat Nurs, 16, pp.560~564 (2010)
- Lim M, "Botulinum toxin in the management of sialorrhea: a systemic review", Clinical Otolaryngol, 31, pp.267~272 (2006)
- Arbouw ME, "Glycopyrrolate for sialorrhea in Parkinson disease: a randomized, double-blind, crossover trial", Neurology, 74, pp.1203~1207 (2010)
- Strutt R, "Nebulized glycopyrrolate for drooling in a motor neuron patient", J Pain Sympatom Mnage, 17, pp.293~295 (1999)
- Han TS, "Effects of transdermal scopolamine on postoperative nausea and vomiting during patients-controlled analgesia", Korean J Anesthesiol, 37, pp.289~294 (1999)
- Lewis DW, "Transdermal scopolamine for reduction of drooling in developmentally delayed children", Dev Med Child Neurol, 36, pp.484~486 (1994)
- Doyle J, "Nebulized scopolamine", J Pain Symptom Manage, 19, pp.237~238 (2000)
- Hyson H, "Sublingual atropine for sialorrhea secondary to parkinsonism: a pilot study", Mov Disord, 17, pp.1318~1320 (2002)
- Dressler D, "Botulinum toxin:mechanisms of action", Eur Neurol, 53, pp.3~9 (2005)
- Bhatia KP, "Botulinum toxin is a useful treatment in excessive drooling in saliva", J Neurol Neurosurg Psychiatry, 67, pp.697~ (1999)
- Sriskandan N, "Ultrasound-guided submandibular gland injection of botulinum tosin for hypersalivation in cerebral palsy", Br J Oral Maxillofac Surg, 48, pp.58~60 (2010)
- Savarese R, "Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy", Am J Phys Med Rehabil, 83, pp.304~311 (2004)
- Suskind DL, "Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy", Laryngoscope, 112, pp.73~81 (2002)
- Rodwell K, "Salivary gland botulinum toxin injections for drooling in children with cerebral palsy and neurodevelopmental disability: a systematic review", Dev Med Child Neurol, 54, pp.977~987 (2012)
- Guidubaldi A, "Botulinum toxin A versus B in sialorrhea: a prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease", Mov Disord, 26, pp.313~319 (2011)
- Kasarskis E, "Unilateral parotid electron beam radiotherapy as palliative treatment for sialorrhea in amyotrophic lateral sclerosis", J Neurol Sci, 308, pp.155~157 (2011)
- Reed J, "Surgical management of drooling", Arch Otolaryngol Head Neck Surg, 135, pp.924~931 (2009)